- Home
- SLDB vs EAF Comparison
SLDB vs EAF Comparison
Compare SLDB & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDB
- EAF
- Stock Information
- Founded
- SLDB 2013
- EAF 1886
- Country
- SLDB United States
- EAF United States
- Employees
- SLDB N/A
- EAF N/A
- Industry
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- EAF Industrial Machinery/Components
- Sector
- SLDB Health Care
- EAF Energy
- Exchange
- SLDB Nasdaq
- EAF Nasdaq
- Market Cap
- SLDB 234.8M
- EAF 265.9M
- IPO Year
- SLDB 2018
- EAF 1995
- Fundamental
- Price
- SLDB $7.00
- EAF $1.54
- Analyst Decision
- SLDB Strong Buy
- EAF Hold
- Analyst Count
- SLDB 10
- EAF 6
- Target Price
- SLDB $15.10
- EAF $1.50
- AVG Volume (30 Days)
- SLDB 1.7M
- EAF 4.7M
- Earning Date
- SLDB 08-12-2025
- EAF 07-25-2025
- Dividend Yield
- SLDB N/A
- EAF N/A
- EPS Growth
- SLDB N/A
- EAF N/A
- EPS
- SLDB N/A
- EAF N/A
- Revenue
- SLDB N/A
- EAF $508,550,000.00
- Revenue This Year
- SLDB N/A
- EAF N/A
- Revenue Next Year
- SLDB N/A
- EAF $26.22
- P/E Ratio
- SLDB N/A
- EAF N/A
- Revenue Growth
- SLDB N/A
- EAF N/A
- 52 Week Low
- SLDB $2.41
- EAF $0.52
- 52 Week High
- SLDB $10.37
- EAF $2.53
- Technical
- Relative Strength Index (RSI)
- SLDB 75.71
- EAF 67.15
- Support Level
- SLDB $5.74
- EAF $0.96
- Resistance Level
- SLDB $7.12
- EAF $1.63
- Average True Range (ATR)
- SLDB 0.48
- EAF 0.17
- MACD
- SLDB 0.11
- EAF 0.05
- Stochastic Oscillator
- SLDB 94.50
- EAF 86.99
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
About EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.